Armata Pharmaceuticals (ARMP) Enterprise Value: 2013-2018
Historic Enterprise Value for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to $6.8 million.
- Armata Pharmaceuticals' Enterprise Value rose 51.99% to $6.8 million in Q4 2018 from the same period last year, while for Dec 2018 it was $6.8 million, marking a year-over-year increase of 147.01%. This contributed to the annual value of $66.9 million for FY2024, which is 42.84% down from last year.
- According to the latest figures from Q4 2018, Armata Pharmaceuticals' Enterprise Value is $6.8 million, which was up 283.04% from -$3.7 million recorded in Q3 2018.
- Over the past 5 years, Armata Pharmaceuticals' Enterprise Value peaked at $71.2 million during Q4 2014, and registered a low of -$4.5 million during Q1 2014.
- Its 3-year average for Enterprise Value is $5.0 million, with a median of $4.7 million in 2017.
- In the last 5 years, Armata Pharmaceuticals' Enterprise Value surged by 1,966.52% in 2017 and then crashed by 1,665.63% in 2018.
- Quarterly analysis of 5 years shows Armata Pharmaceuticals' Enterprise Value stood at $71.2 million in 2014, then tumbled by 80.28% to $14.0 million in 2015, then crashed by 101.70% to -$239,050 in 2016, then soared by 1,966.52% to $4.5 million in 2017, then spiked by 51.99% to $6.8 million in 2018.
- Its Enterprise Value was $6.8 million in Q4 2018, compared to -$3.7 million in Q3 2018 and $3.2 million in Q2 2018.